Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056104 · ClinicalTrials.gov registry record · NA
Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 543
- Enrollment target
NCT04056104: Completed NA study, sponsored by University of California, Davis.
NCT04056104 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 543 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04056104, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 543 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate and create a new clinical prediction model for CCHD screening that combines non-invasive measurements of oxygenation and perfusion.
Primary Outcome
A CCHD screening algorithm will be created by simultaneously measuring oxygen saturation, perfusion index, and pulse oximetry waveform analysis from right upper and any lower extremity in newborns with and without CHD. Investigators will use cross-validation to test the newly developed algorithms and estimate AUROC for the specified types of heart defects. For purposes of defining primary and secondary criterion variables, the CHD will be considered present or absent at enrollment when the infan
Interventions
- DIAGNOSTIC_TEST SpO2 and PIx Measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 543 participants |
| Start Date | 2019-10-23 |
| Est. Completion | 2021-12-12 |
| Phase | NA |
What the finished NCT04056104 record still lists
NCT04056104 is an interventional study that assigns participants to a tested intervention. The registered 543 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 0 conditions, and to 1 intervention - of which SpO2 and PIx Measurement is the first listed.
NCT04056104 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04056104 about?
NCT04056104 is a clinical study titled "Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements". The purpose of this research is to evaluate and create a new clinical prediction model for CCHD screening that combines non-invasive measurements of oxygenation and perfusion.
What is the current status of trial NCT04056104?
This trial is currently completed. It is a NA study. The enrollment target is 543 participants. The study started on 2019-10-23. Estimated completion is 2021-12-12.
What interventions are being tested in trial NCT04056104?
The interventions under investigation include: SpO2 and PIx Measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04056104?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04056104's enrollment target sits among peer trials
543 186th of 2000 higher than 1,814 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07294053 · 543 participants · NA
Sugary Drink Labeling Study
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06118502 · 544 participants · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI